Turnaround story: 40 smallcaps that lost over 30% in FY23, turn multibaggers in FY24

Turnaround story: 40 smallcaps that lost over 30% in FY23, turn multibaggers in FY24

MUMBAI: Undoubtedly, the current financial year has been a remarkable one for the little ninjas of Dalal Street – smallcap stocks – as we saw as many as 181 of them turning multibaggers. What’s worth noting is that more than 100 of these smallcap stocks went through a bad phase in the preceding financial year. … Read more

Euphoria ebbing? Number of smallcap stock gainers plunge 27% week-on-week

Euphoria ebbing? Number of smallcap stock gainers plunge 27% week-on-week

While the benchmarks Sensex and Nifty 50 clocked losses for the fourth straight week, the broader market also lost some of its momentum as was visible in the stock performance. In the week gone by, 55 smallcap stocks gave double-digit positive weekly returns, as compared to 75 stocks a week ago. In the BSE 500 … Read more

CPI data, FII mood among 8 factors to drive D-Street this week

CPI data, FII mood among 8 factors to drive D-Street this week

After losses in the last week, the short-term trajectory of domestic equities is seen as weak, and investors may sit on the fence looking for fresh cues, as the earnings season draws to a close. Therefore, rangebound trade could be seen in indices in the truncated week ahead. The stock markets are closed on Tuesday … Read more

Wockhardt Hospital, Mumbai Central enters into a partnership with HaystackAnalytics – ET HealthWorld

Wockhardt Hospital, Mumbai Central enters into a partnership with HaystackAnalytics – ET HealthWorld

Mumbai: Wockhardt Hospital, Mumbai Central has entered into a partnership with HaystackAnalytics to embark into the realm of precision genomics with the help of whole exome sequencing. By partnering with HaystackAnalytics, Wockhardt Hospital – Mumbai Central aims to leverage the power of genomics to enhance patient care and improve health outcomes. The Genetic Health Plan … Read more

RIL-backed co, new-age techies among 41 firms to post losses for 4 straight quarters

RIL-backed co, new-age techies among 41 firms to post losses for 4 straight quarters

The December quarter earnings were a mixed big, but an analysis of the bottomline performance of the companies showed that as many as 41 of them reported a loss for the fourth straight quarter. The analysis by ETMarkets was done on companies with a minimum market capitalisation of Rs 500 crore. The new-age technology companies, … Read more

Wockhardt inks deal to produce Sputnik V Covid-19 vaccine in India

1 270

Wockhardt will manufacture and supply to Enso up to 620 million doses of the Sputnik V vaccine and the Sputnik Light vaccine, Wockhardt said. Pharmaceutical major Wockhardt will be producing Sputnik V vaccines in India. The company said on Friday it has partnered with the Russian Direct Investment Fund (RDIF) to produce Sputnik V and … Read more

Wockhardt jumps 10%, gains 49% over one month

photo

Mumbai: Drug maker Wockhardt jumped 10 per cent in Thursday’s session in heavy volume trade, extending the recent rally in stock. The trigger for the momentum in the stock could not be ascertained but it is a low free-float stock. Such stocks typically witness sharp volatile moves, depending on developments. At 2:50 pm, the stock … Read more

Wockhardt surges 10% on signing Covid-19 deal with UK government

photo

New Delhi: Shares of Wockhardt surged 10 per cent in Tuesday’s trade after the biotechnology major said it has entered into an agreement with the UK government to fill-finish Covid-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales, the drugmaker said in a BSE filing. … Read more